Apo10 and TKTL1 in blood macrophages as non-invasive biomarkers for early detection of cervical cancer
Cellular Oncology · 2025
DOI: 10.1007/s13402-025-01092-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2025. Verfasst von Shuqing Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Prevention Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen Univ…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Biomarkers, Tumor, Early Detection of Cancer, Macrophages. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Scientific Research Foundation of Guangdong Province of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Purpose
Apo10 and TKTL1 are tumor-associated markers reflecting impaired apoptosis and enhanced glycolysis respectively. This study aimed to evaluate the diagnostic potential of Apo10, TKTL1, and APT (a combination of Apo10 and TKTL1) in screening early-stage cervical cancer.
Methods
A total of 152 patients with cervical cancer and 152 age-matched healthy controls were enrolled at Sun Yat-sen University Cancer Center from November 2020 to August 2023. Clinical data were collected from the Hospital Information System (HIS) and medical records, and blood samples were collected from all participants before treatment using epitope detection in monocytes (EDIM) technology 60 min after their last meal. Descriptive statistics and receiver operating characteristic (ROC) curves were used to compare the diagnostic performance of Apo10, TKTL1, and APT to those of conventional cervical cancer biomarkers (CEA, CA125, and SCC-A).
Results
Most of the enrolled patients with cervical cancer had early-stage disease (70%) and squamous cell histology (84.9%). The Apo10, TKTL1, and APT levels were significantly higher in the cervical cancer group than in the control group (Apo10:139 vs. 132, TKTL1:121 vs. 114, APT: 260 vs. 246). We also found that Apo10, TKTL1, and APT showed superior diagnostic performance (AUC: 0.864, 0.865, 0.905) compared to traditional markers (CEA: 0.690, CA125: 0.594, SCC-A: 0.806). Sensitivity analysis revealed APT maintained high diagnostic value across tumor stages and in both HPV-negative (AUC = 0.967) and TCT-negative (AUC = 0.958) subgroups.
Conclusion
Apo10, TKTL1, and APT outperform conventional biomarkers in detecting cervical cancer and may serve as reliable diagnostic indicators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Prevention Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
- Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
- Department of Gynecologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
- Department of Experimental Research, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.…
- Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Guangzhou, Guangdong, 510060, China. zengmsh@sysucc.org.cn.
- Cancer Prevention Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China. xiechb@sysu…
Förderung
- Medical Scientific Research Foundation of Guangdong Province of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Wang, S., Mao, Z., Liu, Y., Lan, C., Liu, L., Zeng, M., & Xie, C. (2025). Apo10 and TKTL1 in blood macrophages as non-invasive biomarkers for early detection of cervical cancer. Cellular Oncology. https://doi.org/10.1007/s13402-025-01092-3
Vancouver
Wang S, Mao Z, Liu Y, Lan C, Liu L, Zeng M, et al. Apo10 and TKTL1 in blood macrophages as non-invasive biomarkers for early detection of cervical cancer. Cellular Oncology. 2025. doi:10.1007/s13402-025-01092-3
BibTeX
@article{Wang2025,
author = {Wang, Shuqing and Mao, Zhiying and Liu, Yuying and Lan, Chunyan and Liu, Lizhi and Zeng, Musheng and Xie, Chuanbo},
title = {Apo10 and TKTL1 in blood macrophages as non-invasive biomarkers for early detection of cervical cancer},
journal = {Cellular Oncology},
year = {2025},
doi = {10.1007/s13402-025-01092-3}
}
EUVIMED